European urology, vol.45, no.4, 2004 (SCI-Expanded)
Article / Article
Science Citation Index Expanded (SCI-EXPANDED), Scopus
bladder, transitional cell carcinoma, prostatic urethral involvement, carcinoma in situ, BCG, intravesical treatment, BACILLUS-CALMETTE-GUERIN, INTRAVESICAL BCG, CANCER, THERAPY, INSITU, IMMUNOTHERAPY
Dokuz Eylül University Affiliated:
Objective: Treatment of patients with mucosal prostatic urethral transitional cell carcinoma (TCC) is controversial. In this study, we evaluated the outcome of patients with mucosal prostatic urethral TCC who were managed conservatively.